David Jamieson
Northern Institute for Cancer Research
University of Newcastle upon Tyne
Paul O'Gorman Building
Medical School
UK
Name/email consistency: high
- Development and validation of cell-based ELISA for the quantification of trastuzumab in human plasma. Jamieson, D., Cresti, N., Verrill, M.W., Boddy, A.V. J. Immunol. Methods (2009)
- Reduction of mitomycin C is catalysed by human recombinant NRH:quinone oxidoreductase 2 using reduced nicotinamide adenine dinucleotide as an electron donating co-factor. Jamieson, D., Tung, A.T., Knox, R.J., Boddy, A.V. Br. J. Cancer (2006)